Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Assets: 2009-2021

Historic Return on Assets for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Dec 2021 value amounting to -0.34%.

  • Avadel Pharmaceuticals' Return on Assets fell 41.00% to -0.34% in Q4 2021 from the same period last year, while for Dec 2021 it was -0.34%, marking a year-over-year decrease of 41.00%. This contributed to the annual value of -0.31% for FY2021, which is 28.00% down from last year.
  • Avadel Pharmaceuticals' Return on Assets amounted to -0.34% in Q4 2021, which was down 39.92% from -0.25% recorded in Q3 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Return on Assets peaked at 0.30% during Q3 2017, and registered a low of -0.60% during Q2 2019.
  • Over the past 3 years, Avadel Pharmaceuticals' median Return on Assets value was -0.30% (recorded in 2021), while the average stood at -0.28%.
  • In the last 5 years, Avadel Pharmaceuticals' Return on Assets slumped by 67bps in 2018 and then spiked by 56bps in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Return on Assets (Quarterly) stood at 0.26% in 2017, then slumped by 67bps to -0.41% in 2018, then declined by 8bps to -0.49% in 2019, then spiked by 56bps to 0.07% in 2020, then tumbled by 41bps to -0.34% in 2021.
  • Its last three reported values are -0.34% in Q4 2021, -0.25% for Q3 2021, and -0.19% during Q2 2021.